Lucia M. Balsa

La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human Osteosarcoma.

In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human Osteosarcoma.

Journal: Pharmaceutics

Published: December 16, 2025

Advances in copper complexes in cancer treatment.

Advances in copper complexes in cancer treatment.

Journal: Drug discovery today

Published: August 22, 2025

Deciphering the Effect of a Cu(II)-hydrazone Complex on Intracellular Cell Signalling Pathways in a Human Osteosarcoma 2D and 3D Models.

Deciphering the Effect of a Cu(II)-hydrazone Complex on Intracellular Cell Signalling Pathways in a Human Osteosarcoma 2D and 3D Models.

Journal: Chembiochem : a European journal of chemical biology

Published: April 22, 2024

Metallocompounds as anticancer agents against osteosarcoma.

Metallocompounds as anticancer agents against osteosarcoma.

Journal: Drug discovery today

Published: February 12, 2024

New copper(II) and oxidovanadium(IV) complexes with a vitamin B6 Schiff base: mechanism of action and synergy studies on 2D and 3D human osteosarcoma cell models.

New copper(II) and oxidovanadium(IV) complexes with a vitamin B6 Schiff base: mechanism of action and synergy studies on 2D and 3D human osteosarcoma cell models.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: December 19, 2023

Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models.

Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models.

Journal: Chemico-biological interactions

Published: May 16, 2023

Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics.

Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics.

Journal: International journal of molecular sciences

Published: February 06, 2023

Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds.

Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds.

Journal: Molecules (Basel, Switzerland)

Published: January 31, 2023

Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres.

Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres.

Journal: ChemMedChem

Published: August 02, 2021

Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.

Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: June 30, 2021

Copper Complexes as Antitumor Agents: In vitro and In vivo Evidence.

Copper Complexes as Antitumor Agents: In vitro and In vivo Evidence.

Journal: Current medicinal chemistry

Published: May 28, 2021

In silico and in vitro analysis of FAK/MMP signaling axis inhibition by VO-clioquinol in 2D and 3D human osteosarcoma cancer cells.

In silico and in vitro analysis of FAK/MMP signaling axis inhibition by VO-clioquinol in 2D and 3D human osteosarcoma cancer cells.

Journal: Metallomics : integrated biometal science

Published: October 27, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026